Proactive Investors - Run By Investors For Investors

Canntab Therapeutics and Heritage Cannabis strike deal to work together

Heritage Cannabis (CSE:CANN) President and CEO Clint Sharples and Canntab Therapeutics (CSE:PILL) CFO Richard Goldstein joined Christine Corrado from Proactive Investors New York to talk about their partnership that seems to really benefit both companies.

Heritage’s subsidiary Purefarma Solutions will provide processing services for hemp supplied by Canntab, to their specification as required for the production of Canntab’s planned ingestible oral cannabis products. The partnership will start right away. 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here  
View full PILL profile View Profile

Canntab Therapeutics Ltd Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use